HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nigel Loveridge Selected Research

Sclerosteosis

12/2011Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnover.
11/2005Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nigel Loveridge Research Topics

Disease

3Stroke (Strokes)
04/2009 - 01/2006
2Sclerosteosis
12/2011 - 11/2005
1Hip Osteoarthritis (Coxarthrosis)
08/2010
1Growth Disorders
09/2008
1Hemiplegia (Spastic Hemiplegia)
05/2007
1Hip Fractures (Intertrochanteric Fractures)
01/2006

Drug/Important Bio-Agent (IBA)

2Zoledronic Acid (Zometa)FDA Link
04/2009 - 05/2007
1collagen type I trimeric cross-linked peptideIBA
12/2011
1ProcollagenIBA
12/2011
14-hexyloxyaniline (HOA)IBA
08/2010
1SiliconIBA
09/2008
1Diphosphonates (Bisphosphonates)IBA
05/2007
1Vitamin DFDA LinkGeneric
01/2006
1CalciumIBA
01/2006
1Proteins (Proteins, Gene)FDA Link
11/2005

Therapy/Procedure

1Fracture Fixation
08/2010